Relation of the International Restless Legs Syndrome Study Group rating scale with the Clinical Global Impression severity scale, the restless legs syndrome 6-item questionnaire, and the restless legs syndrome-quality of life questionnaire

Sleep Medicine

Volumn 14, Issue 12, 2013, Pages 1375-1380

  Allen, Richard ^a   Oertel, Wolfgang ^b   Walters, Arthur ^c   Benes, Heike ^d   Schollmayer, Erwin ^e   Grieger, Frank ^e   Moran, Kimberly ^e   Kohnen, Ralf ^f,g  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Somni Bene Institut fur Medizinische Forschung und Schlafmedizin   (Germany)

^e UCB PHARMA   (Belgium)

^f Research Pharmaceutical Services Inc   (United States)

^g UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

CGI; IRLS; Restless legs syndrome; RLS 6; RLS QoL; Willis Ekbom disease

Indexed keywords

PLACEBO; ROTIGOTINE;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; END OF MAINTENANCE; FEMALE; HUMAN; INTERNATIONAL RESTLESS LEGS SYNDROME STUDY GROUP RATING SCALE; MAJOR CLINICAL STUDY; MALE; PHASE 3 CLINICAL TRIAL; POST HOC ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RESTLESS LEGS SYNDROME; RESTLESS LEGS SYNDROME 6 ITEM QUESTIONNAIRE; SCORING SYSTEM;

CGI; IRLS; RESTLESS LEGS SYNDROME; RLS-6; RLS-QOL; WILLIS-EKBOM DISEASE;

ADULT; AGED; DOPAMINE AGONISTS; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RESTLESS LEGS SYNDROME; SEVERITY OF ILLNESS INDEX; TETRAHYDRONAPHTHALENES; THIOPHENES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84888129430     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2013.09.008     Document Type: Article

References (18)

1. Trenkwalder C., Paulus W. Restless legs syndrome: pathophysiology, clinical presentation and management. Nat Rev Neurol 2010, 6:337-346.
2. Michaud M., Dumont M., Paquet J., Desautels A., Fantini M.L., Montplaisir J. Circadian variation of the effects of immobility on symptoms of restless legs syndrome. Sleep 2005, 28:843-846.
3. Hogl B., Gschliesser V. RLS assessment and sleep questionnaires in practice-lessons learned from Parkinson's disease. Sleep Med 2007, 8(Suppl. 2):S7-S12.
4. Abetz L., Arbuckle R., Allen R.P., Garcia-Borreguero D., Hening W., Walters A.S., et al. The reliability, validity and responsiveness of the International Restless Legs Syndrome Study Group rating scale and subscales in a clinical-trial setting. Sleep Med 2006, 7:340-349. [published online ahead of print May 19, 2006].
5. Walters A.S., LeBrocq C., Dhar A., Hening W., Rosen R., Allen R.P., et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003, 4:121-132.
6. Kohnen R., Allen R.P., Benes H., Garcia-Borreguero D., Hening W.A., Stiasny-Kolster K., et al. Assessment of restless legs syndrome-methodological approaches for use in practice and clinical trials. Mov Disord 2007, 22(Suppl. 18):S485-S494. [published correction appears in Mov Disord 2008;23:1200-2].
7. Trenkwalder C., Benes H., Poewe W., Oertel W.H., Garcia-Borreguero D., de Weerd A.W., et al. SP790 study group. Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2008, 7:595-604.
8. Benes H., Kohnen R. Validation of an algorithm for the diagnosis of restless legs syndrome: the restless legs syndrome-diagnostic index (RLS-DI). Sleep Med 2009, 10:515-523.
9. Walters A.S. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 1995, 10:634-642.
10. Allen R.P., Kushida C.A., Atkinson M.J. Factor analysis of the International Restless Legs Syndrome Study Group's scale for restless legs severity. Sleep Med 2003, 4:133-135.
11. National Institute of Mental Health Clinical global impressions (028 CGI). ECDEU assessment manual for psychopharmacology 1976, 218-222. National Institute of Mental Health, Rockville (MD). W. Guy (Ed.).
12. Kohnen R., Stiasny-Kolster K., Oertel W.H., Benes H., Trenkwalder C. Severity rating of restless legs syndrome: validation of the RLS-6 scales. Sleep 2004, 27(Suppl. 1):A342.
13. Kohnen R., Benes H., Heinrich C., Kurella B. Development of the disease-specific restless legs syndrome quality of life (RLS-QoL) questionnaire. Mov Disord 2002, 17(Suppl. 5):A232.
14. Wunderlich G.R., Evans K.R., Sills T., Pollentier S., Reess J., Allen R.P., et al. An item response analysis of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2005, 6:131-139.
15. Kohnen R., García-Borreguero D., Allen R., Grieger F., Bauer L., Schollmayer E., et al. Transdermal rotigotine improved daytime functioning and daytime symptoms in patients with idiopathic restless legs syndrome. Mov Disord 2011, 26(2):S362-S363.
16. Earley C.J., Silber M.H. Restless legs syndrome: understanding its consequences and the need for better treatment. Sleep Med 2010, 11:807-815.
17. Abetz L., Arbuckle R., Allen R.P., Mavraki E., Kirsch J. The reliability, validity and responsiveness of the Restless Legs Syndrome Quality of Life questionnaire (RLSQoL) in a trial population. Health Qual Life Outcomes 2005, 3:79.
18. Trenkwalder C., Kohnen R., Allen R.P., Benes H., Ferini-Strambi L., Garcia-Borreguero D., et al. Clinical trials in restless legs syndrome-recommendations of the European RLS Study Group (EURLSSG). Mov Disord 2007, 22(Suppl. 18):S495-S504.